Amiri F, Halabian R, Dehgan Harati M, Bahadori B, Mehdipour A, Mohammadi Roushandeh A, et al. Positive selection of Wharton’s jelly-derived CD105+ cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells. Hematology 2015; 20(4): 208-16.
Choudhery MS, Badowski M, Muise A, Harris DT. Comparison of human mesenchymal stem cells derived from adipose and cord tissue. Cytotherapy 2013; 15(3): 330-43.
Amiri F, Molaei S, Bahadori M, Nasiri F, Deyhim MR,
Jalili MA, et al. Autophagy-modulated Human Bone Marrow-derived Mesenchymal Stem Cells Accelerate Liver Restoration in Mouse Models of Acute Liver Failure. Iran Biomed J 2016; 20(3): 135-44.
Nasiri F, Amiri F, Mohammadipour M, Molaei S, Habibi Roudkenar M, Jalili MA. H2O2-preconditioned mesenchymal stem cell regenerative effects on acute liver failure mice. Sci J Iran Blood Transfus Organ 2015; 12(2): 111-24. [Article in Farsi]
Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplant 2016; 25(5): 829-48.
Tang YL, Tang Y, Zhang YC, Qian K, Shen L and Phillips MI. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005; 46(7): 1339-50.
Amiri F, Jahanian-Najafabadi A, Roudkenar MH. In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments: In vitro augmentation of mesenchymal stem cells viability. Cell Stress Chaperones 2015; 20(2): 237-51.
Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 2004; 37(2): 139-43.
Mehrabi Habibabadi H, Amiri F, Moslemi E, Habibi Roudkenar M, Jalili MA. Overexpression of Nrf2 in
umbilical cord-derived mesenchymal stem cells upregulating cytoprotective genes, TXNRD1 and GCLC. Sci J Iran Blood Transfus Organ 2015; 12(3): 255-65. [Article in Farsi]
Mohammadzadeh M, Halabian R, Gharehbaghian A, Amirizadeh N, Jahanian-Najafabadi A, Roushandeh AM, et al. Nrf-2 overexpression in mesenchymal stem
Soltani F, Amiri F, Kheirandish M, Mohammadipour M, Jalili M, Habibi Roudkenar M, et al. Cell survival evaluation of mesenchaymal stem cells cultivated in the presense of secretome of HIF-1α/Nrf2-engineered-MSC. Sci J Iran Blood Transfus Organ 2016; 12(4): 318-30. [Article in Farsi]
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as global public health problem: approaches and nitiatives a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72(3): 247-59.
Bianchi F, Sala E, Donadei C, Capelli I, La Manna G. Potential advantages of acute kidney injury management by mesenchymal stem cells. World J Stem Cells 2014; 6(5): 644-50.
Reinders ME, Fibbe WE, Rabelink TJ. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant 2010; 25(1): 17-24.
Yew TL, Hung YT, Li HY, Chen HW, Chen LL, Tsai KS, et al. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell Transplant 2011; 20(5): 693-706.
Mohammadzadeh-Vardin M, Habibi Roudkenar M, Jahanian-Najafabadi A. Adenovirus-Mediated
Over-Expression of Nrf2 Within Mesenchymal Stem Cells (MSCs) Protected Rats Against Acute Kidney Injury. Adv Pharm Bull 2015; 5(2): 201-8.
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine,Tehran, Iran
Abstract Background and Objectives
The decrease in mesenchymal stem cells (MSCs) survival rate after transplantation is a major challenge in MSC-cell-therapy. Hence, it is promising to employ some proper strategies for addressing this problem. This study was conducted to assay the therapeutic effects of MSCs treated with Nrf2-manipulated-MSC conditioned medium in acute kidney injury (AKI)-induced animal models.
Materials and Methods
In an experimental study, recombinant plasmid pcDNA3.1-Nrf2 was transfected into bone marrow-derived MSCs and the resulted conditioned medium was harvested. The MSCs was cultivated with Nrf2-manipulated-derived conditioned medium. The conditioned medium-treated-MSCs were transplanted to AKI-induced rats (each group containing 10 rats) and the therapeutic potentialities of these MSCs were evaluated using biochemical and pathological methods.
Results
Fourteen days after MSCs transplantation, there was a significant difference in BUN decreasing in rat groups injected with conditioned medium-treated-MSCs (48 ± 3.5 mg/dL) in comparison with those injected with normal MSCs (100 ± 9.9 mg/dL) (p < 0.001). The number of observed casts (0.26) in kidney tissue sections of these rat groups were also less than (0.51) the groups transplanted with normal MSCS.
Conclusions
Cultivation of MSCs in the presence of Nrf2-manipulated-derived conditioned medium increase the therapeutic effects of these cells in AKI-induced models.
Key words: Mesenchymal Stem Cells, Acute Kidney Injury, Conditioned Medium
Received: 26 Jun 2015 Accepted: 5 Oct 2016
Correspondence: Jalili MA., PhD of Medicinal Chemistry. Assistant Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 82052155; Fax: (+9821) 88601599
E-mail: m.jalili@ibto.ir
Jaleh F, Amiri F, Dehghan Harati M, Habibi Roudkenar M, Jalili M. Evaluation of the repair effects of MSCs cultivated with secretome of Nrf2 engineered MSCs on acute kidney injury in rats. Sci J Iran Blood Transfus Organ 2016; 13 (4) :291-303 URL: http://bloodjournal.ir/article-1-967-en.html